Plain-English translation of NCT06419959 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests a smartwatch application called NightWare, which uses heart rate and movement data to detect when you're having a nightmare and gently interrupts it before it fully wakes you. Researchers believe reducing trauma-related nightmares may improve both sleep quality and cardiovascular health in veterans with PTSD, since nightmares have been linked to heart disease risk. The app recently received special FDA approval as a promising new treatment for nightmare-related sleep problems.
Veterans with PTSD often suffer from nightmares that destroy sleep quality and may increase the risk of heart disease, yet many don't respond well to standard treatments like therapy or medication. This trial exists to see whether this new smartwatch-based approach offers veterans a different option that's easier to access and use at home.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to either receive the active NightWare smartwatch app or a sham (inactive) version for comparison. You'll wear the smartwatch during sleep so it can monitor your heart rate and movement patterns. The study involves periodic check-ins where researchers measure your sleep quality, cardiovascular health markers, and overall well-being. The full duration and visit schedule would be explained during enrollment, but the focus is on tracking how the app affects your nightmares and sleep over time.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States